|
Home - ADARx Pharmaceuticals
Amplifying Science Leveraging our decades of siRNA drug development experience and proprietary technologies, we are focused on developing next-generation siR...
|
88 % |
|
Home | Neurocrine Biosciences
<p>Neurocrine Biosciences — dedicated to discovering and developing life-changing treatments for patients with neurological, psychiatric, and endocrine disor...
|
87 % |
|
Harnessing Breakthrough Science to Advance Hematology Care
Committed to turning scientific discoveries into effective medicines that will disrupt the current standard of care, alleviate suffering, and have a meaningf...
|
87 % |
|
Keros Therapeutics - Powered by TGF-ß science, inspired by patients
Our mission is to innovate therapies that have the potential to shift the treatment of hematological,pulmonary and cardiovascular disorders
|
87 % |
|
Improving Patients' Lives | Jazz Pharmaceuticals
Jazz Pharmaceuticals is focused on improving patients’ lives by identifying, developing, and commercializing products that address unmet medical needs.
|
85 % |
|
Merck | Home
At Merck, we're following the science to tackle some of the world's greatest health threats. Get a glimpse of how we work to improve lives.
|
85 % |
|
MSD | Home
At MSD, we're following the science to tackle some of the world's greatest health threats. Get a glimpse of how we work to improve lives.
|
85 % |
|
Expanding access to essential medicines | Amneal Pharmaceuticals
Amneal is a U.S.-based biopharmaceutical company. We are expanding access to safe, effective and affordable medicines.
|
85 % |
|
GH Research
GH Research is a clinical-stage pharmaceutical company dedicated to transforming the treatment of psychiatric and neurological disorders.
|
85 % |
|
Immuneering | Deep Cyclic Inhibitors for MAPK-Driven Cancers
Immuneering is developing Deep Cyclic Inhibitors to outpace cancer adaptation, improve durability, and preserve patient quality of life in MAPK-driven cancers.
|
85 % |
|
Leading Innovation in Psychiatric Treatment | Alto Neuroscience
We leverage the biology of individuals’ brains to develop personalized and highly effective medicines, helping patients get better faster.
|
85 % |
|
Scilex Holding – Striving to Revolutionize the World of Pain Management
|
85 % |
|
Enliven Therapeutics | Small Molecule Kinase Inhibitors
We are a biopharmaceutical company focused on the discovery and development of small molecule kinase inhibitors to help patients with cancer live longer and...
|
85 % |
|
CG Oncology | Focused on the Future of Bladder Cancer
CG Oncology is a late-stage pharmaceutical company that is passionate about developing and delivering bladder-sparing immunotherapies.
|
85 % |
|
Genentech
Breakthrough science. One moment, one day, one person at a time.
|
84 % |
|
Haemonetics®
Haemonetics provides a suite of innovative medical technology solutions that improve the quality, effectiveness and efficiency of care. We challenge ourselve...
|
84 % |
|
Homepage | Newron Pharmaceuticals
We are a biopharmaceutical company focused on the development of novel therapies for patients with diseases of the central and peripheral nervous system
|
84 % |
|
Arch Biopartners
|
84 % |
|
Crinetics | Driving the Next Generation of Endocrinology Care
Crinetics is here for endocrine disease patients who are eager to find therapies that provide effective disease control and more simplicity in their lives.
|
84 % |
|
Innovating to Change the Course of Human Health | IONIS
Discover how we are enabling better futures for people living with serious disease through groundbreaking innovations. Learn about our mission here.
|
84 % |
Detected social media networks